Barclays
SURF

Barclays’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Barclays’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-29,251
Closed -$20.4K – 5263
2023
Q1 		$20.4K Sell
29,251
-78,066
-73% -$63.3K ﹤0.01% 4655
2022
Q4 		$88K Sell
107,317
-310,448
-74% -$306K ﹤0.01% 4302
2022
Q3 		$434K Sell
417,765
-13,043
-3% -$20.8K ﹤0.01% 2787
2022
Q2 		$707K Buy
430,808
+325,689
+310% +$676K ﹤0.01% 2614
2022
Q1 		$310K Buy
105,119
+43,484
+71% +$152K ﹤0.01% 3189
2021
Q4 		$295K Buy
61,635
+36,797
+148% +$237K ﹤0.01% 3427
2021
Q3 		$189K Sell
24,838
-34,668
-58% -$222K ﹤0.01% 3648
2021
Q2 		$444K Sell
59,506
-33,142
-36% -$255K ﹤0.01% 3145
2021
Q1 		$723K Buy
92,648
+92,562
+107,630% +$925K ﹤0.01% 2968
2020
Q4 		$1K Buy
+86
New +$747 ﹤0.01% 4837
2020
Q3 		– Sell
-10,388
Closed -$68K – 5704
2020
Q2 		$68K Buy
+10,388
New +$37.5K ﹤0.01% 4769
2020
Q1 		– Sell
-20,317
Closed -$38K – 6573
2019
Q4 		$38K Sell
20,317
-784
-4% -$1.31K ﹤0.01% 5828
2019
Q3 		$30K Sell
21,101
-4,354
-17% -$9.51K ﹤0.01% 6113
2019
Q2 		$71K Buy
25,455
+21,960
+628% +$87.4K ﹤0.01% 5920
2019
Q1 		$16K Buy
+3,495
New +$17.2K ﹤0.01% 6437
2018
Q4 		– Sell
-2,724
Closed -$30K – 7467
2018
Q3 		$30K Buy
2,724
+2,192
+412% +$25.7K ﹤0.01% 6320
2018
Q2 		$9K Buy
+532
New +$7.7K ﹤0.01% 6584

Other funds holding SURF

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Barclays's SURF Position: Q2 2023 in Review

Barclays sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2023, closing a stake of 29,251 shares — an estimated $20.4K sold.

Barclays first reported a position in SURF in Q2 2018 and held it in 17 quarters. The position peaked at $723K in Q1 2021. 61 funds tracked by Wall St. Rank hold SURF as of Q2 2023.

  • Barclays reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Barclays sold 29,251 Surface Oncology, Inc. Common Stock shares in Q2 2023, an estimated $20.4K.
  • Barclays first reported a position in Surface Oncology, Inc. Common Stock in Q2 2018 and held it in 17 quarters.
  • Barclays's Surface Oncology, Inc. Common Stock position peaked at $723K in Q1 2021.
  • 61 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2023.

Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.